We used continuous measures of disease activity as our primary outcomes: the disease activity score 28 with C-reactive protein (DAS28-CRP) for PsA and RA,27 the AS disease activity score with CRP (ASDAS-CRP) for AS,28 and the psoriasis area and severity index (PASI) score for Pso.29 Here, CRP is linked to psoriasis.